Market Research Reports- Consulting Analysis Crystal Market Research Digital Therapeutics Market by Application and End | Página 2

is expected to grow with fastest CAGR during the forecast period due to high prevalence of diabetes and
large scale use of mHealth by practitioners to treat diabetes. According to the University of Florida
Diabetes Institute, there are more than 1,000 android and iOS apps specifically designed for diabetes
diagnosis and monitoring.
U.S. dominates the North American digital therapeutics market due to growing prevalence of chronic
diseases coupled with increasing geriatric population and high adoption of technologically advanced
devices. Emerging market such as India and China are poised to witness favorable growth over the
forecast period due to rising awareness about digital therapeutics solutions and increasing focus on
advancement in healthcare infrastructure in the region. Entrance of global players in these emerging
markets will further boost the market growth. For instance, in March 2017, WellDoc, Inc. in association
with Max Healthcare and International Finance Corporation launched the WellDoc’s BlueStar mobile
application in India to improve diabetes care.
The companies operating in the global digital therapeutics market emphasize on product development
coupled with technological advancements to secure competitive advantage in the market. For instance, in
May 2015, Mango Health launched a suite of new Mango Health Habit Features integrated with the
Google Fit health tracking platform.
Request a sample copy of Digital Therapeutics Market Research Report @
http://www.crystalmarketresearch.com/report-sample/HC0629
Some of the major players in this market are 2Morrow, Inc., Livongo Health, Propeller Health, Proteus
Digital Health, Omada Health, Inc., WellDoc Inc., Twine Health, Inc., Canary Health, Inc., Mango
Health, Inc. and Noom, Inc.
Key Findings of the Research Study:




Diabetes market is expected to grow at a fastest CAGR over the forecast period due to a rise in
the global prevalence of diabetes.
Preventive market segment is expected to witness highest growth during forecast period due to
increase in demand for early detection and prevention techniques.
North America held the largest share of the global digital therapeutics market in 2016, owing to
the presence of numerous digital therapeutics providers in the region focusing on technological
advancements and high adoption of advanced medical solutions.
In 2016, Europe accounted for the second largest share owing to increase implantation of
telemedicine for better disease care.